None listed
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr. Reddys Laboratories Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: Dermatologists treating chronic pruritus cases, practicing in any healthcare set-up/ clinics/ Hospitals/ Medical colleges in India and having a minimum of 5 years of clinical experience.
Exclusion criteria
Exclusion criteria: Dermatologists unwilling to voluntarily participate in the study and/or provide written consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the level of knowledge about chronic pruritus, its causes, and the role of antihistamines in its management among practicing dermatologists.Timepoint: 10 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the current practices of antihistamine use for chronic pruritus among practicing dermatologists, including adherence rates, dosage recommendations, and treatment duration.Timepoint: 10 weeks;To understand the attitude of practicing dermatologists towards antihistamine use for chronic pruritus, including perceived effectiveness, safety concerns, and side effects.Timepoint: 10 weeks | — |
Countries
India
Contacts
Public ContactSagar Katare
Dr. Reddy’s Laboratories Ltd.
Outcome results
None listed